Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-06
2011-11-15
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S579000, C514S766000, C546S192000
Reexamination Certificate
active
08058291
ABSTRACT:
The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
REFERENCES:
patent: 4148896 (1979-04-01), Smith et al.
patent: 4273774 (1981-06-01), Scherm
patent: 4346112 (1982-08-01), Henkel et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 4769027 (1988-09-01), Baker et al.
patent: 4812481 (1989-03-01), Reischig et al.
patent: 4861800 (1989-08-01), Buyske
patent: 4897268 (1990-01-01), Tice et al.
patent: 4904681 (1990-02-01), Cordi et al.
patent: 5057321 (1991-10-01), Edgren et al.
patent: 5061703 (1991-10-01), Bormann et al.
patent: 5061721 (1991-10-01), Cordi et al.
patent: 5086072 (1992-02-01), Trullas et al.
patent: 5162346 (1992-11-01), Lobisch et al.
patent: 5190763 (1993-03-01), Edgren et al.
patent: 5192550 (1993-03-01), Edgren et al.
patent: 5221536 (1993-06-01), Edgren et al.
patent: 5334618 (1994-08-01), Lipton
patent: 5358721 (1994-10-01), Guittard et al.
patent: 5382601 (1995-01-01), Nurnberg et al.
patent: 5395626 (1995-03-01), Kotwal et al.
patent: 5484608 (1996-01-01), Rudnic et al.
patent: 5614560 (1997-03-01), Lipton et al.
patent: 5648087 (1997-07-01), Ovaert et al.
patent: 5891885 (1999-04-01), Caruso
patent: 5912013 (1999-06-01), Rudnic et al.
patent: 5919826 (1999-07-01), Caruso
patent: 6046232 (2000-04-01), Kelleher et al.
patent: 6057364 (2000-05-01), Jasys et al.
patent: 6066652 (2000-05-01), Zenner et al.
patent: 6114392 (2000-09-01), Gilad et al.
patent: 6187338 (2001-02-01), Caruso et al.
patent: 6194000 (2001-02-01), Smith et al.
patent: 6217905 (2001-04-01), Edgren et al.
patent: 6284276 (2001-09-01), Rudnic et al.
patent: 6384083 (2002-05-01), Ludwig et al.
patent: 6392104 (2002-05-01), Ishii et al.
patent: 6444702 (2002-09-01), Wang et al.
patent: 6479553 (2002-11-01), McCarthy
patent: 6491949 (2002-12-01), Faour et al.
patent: 6620845 (2003-09-01), Wang et al.
patent: 6717012 (2004-04-01), Wang et al.
patent: 6852889 (2005-02-01), Wang et al.
patent: 7619007 (2009-11-01), Went et al.
patent: 2002/0071863 (2002-06-01), Dong et al.
patent: 2003/0203055 (2003-10-01), Rao et al.
patent: 2004/0087658 (2004-05-01), Moebius
patent: 2004/0102525 (2004-05-01), Kozachuk
patent: 2004/0122090 (2004-06-01), Lipton
patent: 2004/0224020 (2004-11-01), Schoenhard
patent: 2005/0031651 (2005-02-01), Gervais et al.
patent: 2005/0065219 (2005-03-01), Lipton et al.
patent: 2005/0124701 (2005-06-01), Went et al.
patent: 2005/0153953 (2005-07-01), Trippodi-Murphy et al.
patent: 2005/0191349 (2005-09-01), Boehm et al.
patent: 2005/0208132 (2005-09-01), Sathyan et al.
patent: 2005/0209218 (2005-09-01), Meyerson et al.
patent: 2005/0020319 (2005-10-01), Kim et al.
patent: 2005/0245460 (2005-11-01), Meyerson et al.
patent: 2005/0245617 (2005-11-01), Meyerson et al.
patent: 2006/0051416 (2006-03-01), Rastogi et al.
patent: 2006/0052370 (2006-03-01), Meyerson et al.
patent: 2006/0062851 (2006-03-01), Vergez et al.
patent: 2006/0063810 (2006-03-01), Vergez et al.
patent: 2006/0079578 (2006-04-01), Laurin et al.
patent: 2006/0142398 (2006-06-01), Went et al.
patent: 2006/0159763 (2006-07-01), Meyer et al.
patent: 2006/0160852 (2006-07-01), Kimura et al.
patent: 2006/0189694 (2006-08-01), Went et al.
patent: 2006/0240043 (2006-10-01), Meyerson et al.
patent: 2006/0246003 (2006-11-01), Kimura et al.
patent: 2007/0065512 (2007-03-01), Dedhiya et al.
patent: 2008/0279819 (2008-11-01), Went et al.
patent: 2010/0047342 (2010-02-01), Went et al.
patent: 2010/0137448 (2010-06-01), Lipton et al.
patent: 2002323873 (2001-01-01), None
patent: 2323805 (1999-09-01), None
patent: 0392059 (1990-10-01), None
patent: 0451484 (1991-10-01), None
patent: 0488959 (1991-11-01), None
patent: 0488959 (1992-08-01), None
patent: 0502642 (1992-09-01), None
patent: 0870757 (1998-10-01), None
patent: 0927711 (1999-07-01), None
patent: 0870757 (2000-06-01), None
patent: 1509232 (2003-12-01), None
patent: 0452484 (2004-07-01), None
patent: 1173492 (1969-12-01), None
patent: 58-4718 (1983-01-01), None
patent: 10203966 (1998-08-01), None
patent: WO 89/09051 (1989-10-01), None
patent: WO 91/06291 (1991-05-01), None
patent: WO 91/14445 (1991-10-01), None
patent: WO 94/05275 (1994-03-01), None
patent: WO 94/06428 (1994-03-01), None
patent: WO 95/13796 (1995-05-01), None
patent: WO 97/14415 (1997-04-01), None
patent: WO 98/18457 (1998-03-01), None
patent: WO 98/27961 (1998-07-01), None
patent: WO 98/27961 (1998-09-01), None
patent: WO 00/18378 (2000-04-01), None
patent: WO 00/56301 (2000-09-01), None
patent: WO 00/56301 (2000-12-01), None
patent: WO 01/19901 (2001-03-01), None
patent: WO 01/32115 (2001-05-01), None
patent: WO 01/32148 (2001-05-01), None
patent: WO 01/46291 (2001-06-01), None
patent: WO 01/62706 (2001-08-01), None
patent: WO 01/19901 (2001-09-01), None
patent: WO 2003/101458 (2003-12-01), None
patent: 2004012700 (2004-02-01), None
patent: WO 2004/012700 (2004-02-01), None
patent: WO 2004/012700 (2004-04-01), None
patent: WO 2004/037234 (2004-05-01), None
patent: WO 2004/056335 (2004-07-01), None
patent: WO 2004/037234 (2004-08-01), None
patent: WO 2004/087116 (2004-10-01), None
patent: WO 2004/056335 (2004-11-01), None
patent: WO 2004/087116 (2004-12-01), None
patent: WO 2004/112768 (2004-12-01), None
patent: 2005065645 (2005-07-01), None
patent: WO 2005/065645 (2005-07-01), None
patent: 2005072705 (2005-08-01), None
patent: WO 2005/072705 (2005-08-01), None
patent: WO 2005/065645 (2005-10-01), None
patent: WO 2005/092009 (2005-10-01), None
patent: WO 2006/009769 (2006-01-01), None
patent: WO 2005/092009 (2006-02-01), None
patent: WO 2006/070781 (2006-07-01), None
patent: WO 2006/089494 (2006-08-01), None
patent: WO 2006/138227 (2006-12-01), None
2006 Chemical Abstracts Service Catalog. Published 2006 by Chemical Abstracts Service, p. 52.
Avery's Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics, 3rd Edition, 1987, edited by Trevor M. Speight, Chapter VIII, pp. 255-282.
Bentue-Ferrer, et al. Medication in Alzheimer's disease, Rev. Geriatr. 26(6):511-522 (2001), (in French with English summary).
Braga, et al. Making crystals from crystals: a green route to crystal engineering and polymorphism, Chemical Communications pp. 3635-3645 (2005).
Cacabelos, et al. Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics, Drugs Today 36(7):415-499 (2000).
Dooley, et al. Donepezil: A review of its use in Alzheimer's Disease, Drugs and Aging 16(3):199-226 (2000).
Feldman, et al. A 24-Week, randomized double-blind study of donepezil in moderate to severe Alzheimer's Disease, Neurology 57:613-20 (2001).
Fuchsberger, et al. Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer, MMW Fortschr Med., 144(20):36-9 (2002) (in German with English summary).
Gauthier, et al. Functional, Cognitive, and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease, Current Medical Research and Opinion® 18(6):347-54 (2002).
Jain, et al. Polymorphism in Pharmacy, Indian Drugs 23(6):315-29 (1986).
Pharmaceutical Dosage Forms: Tablets, Second Edition, Revised and Expanded, published by Marcel Dekker, Inc., edited by Lieberman, Lachman, and Schwartz, pp. 462-472 (1990).
Silverman, R. The Organic Chemistry of Drug Design and Drug Action, published 1992 by Academic Press, pp. 19-21 and 352-401.
The Merck Manual of Diagnosis and Therapy, 17th Edition, published 1999 by Merck Research Laboratories, pp. 1393-1400.
Vippagunta, et al. Crystalline Solids, Advanced Drug Delivery Reviews 48:3-26 (2001).
Yang, et al. Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury, Bioorganic and Medicinal Chemistry Letters 14:2537-41 (2004).
Hartmann S., et al., Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy, Int. Clin. Psychopharmacol. 2003, 18(2):81-85.
Jain, Evaluation of memantine
Fultz Timothy J.
Went Gregory T.
Adamas Pharmaceuticals, Inc.
Carter Kendra D
Padmanabhan Sreeni
Wilson Sonsini Goodrich & Rosati
LandOfFree
Methods and compositions for the treatment of CNS-related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the treatment of CNS-related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of CNS-related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4285134